Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,505 papers from all fields of science
Search
Sign In
Create Free Account
E 5531
Known as:
E-5531
, E5531
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Lipid A
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood.
C. Bryant
,
Andre J. Ouellette
,
+4 authors
Belinda A. Farnfield
Veterinary Immunology and Immunopathology
2007
Corpus ID: 24163634
Highly Cited
2001
Highly Cited
2001
A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway*
E. Lien
,
Jesse C. Chow
,
+5 authors
D. Golenbock
Journal of Biological Chemistry
2001
Corpus ID: 20980449
ER-112022 is a novel acyclic synthetic lipid A analog that contains six symmetrically organized fatty acids on a noncarbohydrate…
Expand
2000
2000
Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins
J. Rose
,
M. Mullarkey
,
+6 authors
D. Rossignol
Antimicrobial Agents and Chemotherapy
2000
Corpus ID: 13062427
ABSTRACT E5531, a novel synthetic lipid A analogue, antagonizes the toxic effects of lipopolysaccharide, making it a potential…
Expand
2000
2000
The Effect of Divalent Cations on the Membrane Properties and Pharmacokinetics in Rat of the Lipid A Analogue E5531
Y. Asai
,
Y. Sano
,
K. Kikuchi
,
K. Iwamoto
,
Sumio Watanabe
The Journal of pharmacy and pharmacology
2000
Corpus ID: 1327371
To obtain information on the effects of Ca2+ on the membrane properties of the lipid A analogue E5531, we have determined the…
Expand
Highly Cited
1999
Highly Cited
1999
E5531, a synthetic non‐toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide
T. Kawata
,
J. Bristol
,
+8 authors
Yoshito Kishi
British Journal of Pharmacology
1999
Corpus ID: 10699057
The major pathological responses to Gram‐negative bacterial sepsis are triggered by endotoxin or lipopolysaccharide. As endotoxin…
Expand
1999
1999
Lipoprotein Distribution of a Novel Endotoxin Antagonist, E5531, in Plasma from Human Subjects with Various Lipid Levels
K. Wasan
,
F. Strobel
,
+4 authors
D. Rossignol
Antimicrobial Agents and Chemotherapy
1999
Corpus ID: 44720559
ABSTRACT The purpose of this study was to determine the distribution profile of a novel endotoxin antagonist, [14C]E5531, at 1 μg…
Expand
1999
1999
The effect of the lipid A analog, E5531 on fever induced by endotoxin from Escherichia coli.
Y. Asai
,
Y. Nozu
,
T. Ikeuchi
,
R. Narazaki
,
K. Iwamoto
,
S. Watanabe
Biological and Pharmaceutical Bulletin
1999
Corpus ID: 28301822
E5531 is a specific lipid A antagonist and is expected to be a drug for the treatment of septic shock. The LAL (limulus amebocyte…
Expand
1998
1998
The effect of the lipid A analog E5531 on phospholipid membrane properties
Y. Asai
,
K. Iwamoto
,
Sumio Watanabe
FEBS Letters
1998
Corpus ID: 603011
Highly Cited
1995
Highly Cited
1995
E5531, a pure endotoxin antagonist of high potency.
W. Christ
,
O. Asano
,
+7 authors
M. Mullarkey
Science
1995
Corpus ID: 3069107
Shock due to Gram-negative bacterial sepsis is a consequence of acute inflammatory response to lipopolysaccharide (LPS) or…
Expand
1995
1995
Anti-endotoxin activity of a novel synthetic lipid A analog.
T. Kawata
,
J. Bristol
,
+7 authors
Y. Kishi
Progress in clinical and biological research
1995
Corpus ID: 45130388
Lipid As from non-toxic bacteria such as Rhodobacter capsulatus and Rhodobacter sphaeroides have been shown to antagonize the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required